BIRC6
BIRC6 (baculoviral IAP repeat containing 6, also known as BRUCE) is an anti-apoptotic inhibitor of apoptosis protein that combines ubiquitin-conjugating and ubiquitin-ligase activities in one polypeptide. It controls cell death by regulating caspases and also contributes to the final stages of cytokinesis. Browse Assay Genie's current range of BIRC6 research reagents below, or read on for the biology behind the target.
BIRC6 is an inhibitor of apoptosis (IAP) protein that regulates cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase. Unlike most IAPs, it has no RING domain and is not a RING-type E3 ligase. Instead it works as a dual E2/E3 enzyme, joining ubiquitin conjugating (E2) and ubiquitin ligase (E3) activities in a single polypeptide. Ubiquitination depends on the non-canonical E1 ubiquitin activating enzyme UBA6.
Among its substrates, BIRC6 ubiquitinates the caspases CASP3, CASP7 and CASP9 and inhibits their activity. It also ubiquitinates their procaspases, though to a weaker extent. It acts on the pro-apoptotic factors DIABLO/SMAC and HTRA2 as well. DIABLO/SMAC antagonises the caspase-inhibiting activity of BIRC6 by competing for the same binding sites as the caspases. BIRC6 also ubiquitinates the autophagy protein MAP1LC3B, and DIABLO/SMAC inhibits this activity too.
Beyond apoptosis, BIRC6 is an important regulator of the final stages of cytokinesis. It is crucial for normal vesicle targeting to the site of abscission and for the integrity of the midbody and midbody ring. Its reported locations include the trans-Golgi network membrane, endosomes, spindle poles, centrosomes and the midbody ring. The BIRC6 gene encodes a protein with a BIR (baculoviral IAP repeat) domain and a UBCc (ubiquitin-conjugating enzyme E2, catalytic) domain. It belongs to the BIRC6 family, and HGNC groups it with the ubiquitin conjugating E2 enzymes, baculoviral IAP repeat containing proteins and atypical E3 ubiquitin ligases. The gene is also listed as a microRNA host gene.
BIRC6 inhibits apoptosis by ubiquitinating CASP3, CASP7 and CASP9, making it a useful focus for studying how cells restrain caspase activity.
As a dual E2/E3 enzyme that works with the non-canonical E1 UBA6 and lacks a RING domain, BIRC6 is a distinctive model of ubiquitin transfer.
BIRC6 is important for vesicle targeting to the abscission site and for midbody and midbody ring integrity in the final stages of cytokinesis.
BIRC6 ubiquitinates MAP1LC3B, and DIABLO/SMAC inhibits this activity, linking the protein to autophagy and to pro-apoptotic antagonism.
BIRC6 is an anti-apoptotic IAP protein that acts as a dual E2/E3 ubiquitin enzyme. It ubiquitinates CASP3, CASP7, CASP9, DIABLO/SMAC, HTRA2 and MAP1LC3B, and it helps regulate the final stages of cytokinesis, including midbody integrity.
BIRC6 is also known as BRUCE. Its previous name was baculoviral IAP repeat-containing 6, and UniProt describes it as the dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6. Its enzyme classification is EC 2.3.2.24.
Unlike most IAPs, BIRC6 has no RING domain and is not a RING-type E3 ligase. It combines E2 and E3 activities in one polypeptide. Related IAP family members such as BIRC2, BIRC3 and BIRC7 are separate genes. Mouse has an ortholog, Birc6; check the datasheet of any product for its validated reactivity.
Other baculoviral IAP repeat containing proteins that regulate apoptosis and ubiquitin signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NR09; product specifications from Assay Genie datasheets.